Sep 6, 2019
This week in our Your Stock, Our Take segment we take a look at Hamilton Thorne Ltd. (HTL:TSX-V), which provides precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets. The company has performed well over the past 3-years growing revenues from the $10 million range to over $30 million annualized. The stock is flat to slightly negative over the past 52-weeks and a listener asks us our take on the current valuation multiples for the stock- is it a BUY/SELL or HOLD?

Sign up for the Stock Talk Podcast

Be the first to find out the latest Keystone Financial news, special reports, receive our Stock Talk Podcast, DIY Seminar event info, and Your Stock Our Take videos directly to your inbox for free.